Domů › Metastatický karcinom › Kentucky › Lexington
Klinické studie Metastatický karcinom v Lexington, KY
11 studií pro Metastatický karcinom hledá účastníky v lokalitách v Lexington a okolí (do cca 30 mil). Otevřete studii a zjistěte, kdo se může zapojit a jak kontaktovat tým studie.
Oficiální text studie (anglicky)
Hledáte účastníky pro studii? Zvýrazněte ji nahoře na této stránce – $99 na 30 dní →
Targeted Therapy Directed by Genetic Testing in Treating Patients With Locally Advanced or Advanced Solid Tumors, The ComboMATCH Screening Trial
Probíhá náborFáze 2
- CommonSpirit Saint Joseph Medical Center - East Lexington, Lexington
- University of Kentucky/Markey Cancer Center, Lexington
Testing the Safety and Tolerability of the Anti-cancer Drugs Trastuzumab Deruxtecan and Neratinib for Cancers With Changes in the HER2 Gene
Probíhá náborFáze 1
- University of Kentucky/Markey Cancer Center, Lexington
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
Probíhá náborFáze 2/3
- University of Kentucky Markey Cancer Center, Lexington
Symbiotic-GI-03: A Study to Learn About the Study Medicine Called PF-08634404 in Combination With Chemotherapy in Adult Participants With Metastatic Colorectal Cancer
Probíhá náborFáze 3
- Baptist Health Lexington, Lexington
- Baptist Health Richmond, Lexington
- Baptist Health Hamburg, Lexington
- a dalších 3
A Study to Learn About the Medicine Ponsegromab in Adults With Cancer of the Pancreas Which Has Spread and Caused Significant Body Weight Loss and Fatigue
Probíhá náborFáze 2/3
- University of Kentucky Research Foundation, Lexington
- University of Kentucky Healthcare - Markey Cancer Center, Lexington
- University of Kentucky Medical Center, Lexington
- a dalších 1
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
Probíhá náborFáze 3
- Baptist Health Lexington, Lexington
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
Probíhá náborFáze 3
- CHI Saint Joseph Cancer Center - East, Lexington
- University of Kentucky Chandler Medical Center, Lexington
Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)
Probíhá náborFáze 2
- University of Kentucky/Markey Cancer Center, Lexington
A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
Probíhá náborFáze 1/2
- Crinetics Study Site, Lexington
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Probíhá náborFáze 1
- UK Markey Cancer Center, Lexington
A Study of CLSP-1025 in Adult Patients With Solid Tumors That Harbor the p53 R175H Mutation
Probíhá náborFáze 1
- University of Kentucky Markey Cancer Center, Lexington
Studie Metastatický karcinom v jiných městech
- Houston, TX104 studií
- New York City, NY93 studií
- Nashville, TN70 studií
- Boston, MA63 studií
- Los Angeles, CA57 studií
- St. Louis, MO54 studií
- Arlington, VA53 studií
- Philadelphia, PA46 studií
- Chicago, IL45 studií
- San Antonio, TX44 studií
- Washington, DC43 studií
- Dallas, TX42 studií
Další studie v Lexington
- Nemalobuněčný plicní karcinom23 studií
- Rakovina plic18 studií
- Rakovina vaječníků16 studií
- Rakovina prostaty14 studií
- Rakovina (všechny typy)14 studií
- Rakovina prsu14 studií
- Kolorektální karcinom11 studií
- Srdeční selhání11 studií
- Melanom10 studií
- Akutní myeloidní leukemie10 studií
- Obesity10 studií
- Squamózní buněčný karcinom hlavy a krku9 studií
Zdroj: ClinicalTrials.gov, data načtena 6. 10. 2026. Každá studie má vlastní kritéria způsobilosti; o účasti rozhoduje tým studie.